We are live on ! Find out more
ST

Skorpios Trust Portfolio holdings

AUM $53.2M
1-Year Est. Return 90.96%
This Fund
S&P 500
This Quarter Est. Return
-15.94%
1 Year Est. Return
+90.96%
3 Year Est. Return
+173.58%
5 Year Est. Return
10 Year Est. Return
AUM
$376M
AUM Growth
-$76.4M
Cap. Flow
-$16K
Cap. Flow %
-0%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
OGN icon
Organon & Co
OGN
+$16K

Sector Composition

Rank Sector Weight
1 Healthcare 99.5%
2 Technology 0.46%
3 Miscellaneous 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STOK icon
1
Stoke Therapeutics
STOK
$1.92B
$304M 80.96%
14,443,681
AKRO
2
DELISTED
Akero Therapeutics
AKRO
$69.6M 18.54%
4,907,829
ATVI
3
DELISTED
Activision Blizzard
ATVI
$1.73M 0.46%
21,600
XBI icon
4
State Street SPDR S&P Biotech ETF
XBI
$11.7B
$152K 0.04%
1,686
OGN icon
5
Organon & Co
OGN
$3.62B
-530
Closed -$16K

Similar funds

Skorpios Trust's Q1 2022 Portfolio in Review

As of Q1 2022, Skorpios Trust held 5 positions worth $376M, down 17% from $452M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Skorpios Trust's Q1 2022 filing shows 1 closed position. The largest sale was Organon & Co, an estimated $16K.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier, followed by Technology and Miscellaneous.

  • Skorpios Trust fully exited Organon & Co in Q1 2022, selling an estimated $16K.
  • Skorpios Trust's ten largest holdings make up 100% of its $376M portfolio in Q1 2022.
  • Skorpios Trust opened 0 new positions and closed 1 in Q1 2022.
  • Skorpios Trust's portfolio value fell 17% quarter-over-quarter to $376M.

Based on Skorpios Trust's 13F filing for Q1 2022, filed 22 Apr 2022.